Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial

DOI: 10.1371/journal.pone.0154842

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text